Biotechnology consortia versus multifirm alliances: Paradigm shift at work?: A new type of collaboration is emerging in biotechnology

Nature Biotechnology

Volumn 14, Issue 13, 1996, Pages 1657-1660

  Persidis, Aris ^a   Persidis, Andreas ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ASSETT   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; DRUG INDUSTRY; DRUG RESEARCH; DRUG SYNTHESIS; FINANCE; GENE THERAPY; INVESTMENT; PATENT; PRIORITY JOURNAL; REVIEW;

BIOTECHNOLOGY; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG INDUSTRY; EUROPEAN UNION; GENE THERAPY; GENOMIC LIBRARY; INTELLECTUAL PROPERTY; INTERNATIONAL COOPERATION; RESEARCH SUPPORT; UNITED STATES;

EID: 0029852796     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1296-1657     Document Type: Article

References (8)

1. De Taxis du Poet, P., Vassarotti, A., and Baselga de Elorz, J. (Eds.). 1995. “Biotechnology—Progress Report 1992-1994” Vol. 1. The European Commission, Brussels, Belgium.
2. Peale, M. 1994. Diversity Biotechnology Consortium: Searches for irrational cures. Bull. Santa Fe Inst. 9:18-20.
3. O’Brian, C. 1994. Networking gene therapy. Science 266:1151.
4. Glazer, V. 1995. Pfizer creates genomics consortium, Pfizergen. Bio/Technology 13:534-535.
5. Lee, K.B. Jr., and Burrill, S.G. 1995. Biotech 96: Pursuing Sustainability. The Tenth Industry Annual Report. Ernst & Young LLP, London.
6. Bullock, W.O. and Dibner, M.D. 1995. The state of the US biotechnology industry. Trends Biotechnol. 13:723-728.
7. Persidis, A. 1996. Building molecular value. J. Business Strat. 17:18-20.
8. Persidis, A. 1995. Enabling technologies and the business of science. Bio/Technology 13:1172-1176.